Machine Learning

A new partnership puts a powerful Southeast Asian language model on local devices, promising enhanced privacy, lower costs, and culturally relevant AI for all.

With a new lineup including a $699 model, ZWHAND's debut at CES 2026 could accelerate the mass adoption of dexterous robots in every field.

Two industry giants are teaming up to build the autonomous labs of tomorrow, promising to revolutionize scientific discovery at an unprecedented scale.

Following a massive stock surge, post-acute care leader PACS Group will detail its strategy for navigating industry headwinds at a premier investor event.

The biotech firm faces a delisting threat after its equity turned negative. Can recent funding save its Nasdaq spot and its ambitious drug pipeline?

Bitdeer reports a massive 339% surge in Bitcoin mining while aggressively expanding its AI cloud services with cutting-edge NVIDIA GB200 GPUs.

ServiceNow executive Paul Fipps joins NetApp's board, bringing deep AI and customer ops expertise to accelerate the company's intelligent data strategy.

New rules will soon require frequent certificate renewals. A new partnership aims to help Aussie firms automate, as manual processes become impossible.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

Pimicotinib, a once-daily pill for tenosynovial giant cell tumor, gains FDA review, offering new hope for patients beyond invasive surgery.

Accelint has won a key role in the MDA's $151B SHIELD program, signaling a major shift toward AI and autonomous systems in national missile defense.

A new drill-free cavity treatment is regenerating teeth, attracting Wall Street, and aiming to solve a global health crisis. This is the story of Curodont™.

Cosmetics brand Sorevna is diving into the crowded bath and body sector, promising a revolutionary launch. But can its science-first approach succeed?

The deal completes insitro’s TherML platform, integrating physics-informed AI to design better drugs faster by solving efficacy and manufacturing hurdles at once.

Recognized by ISG, EXL is transforming insurance with GenAI and data, boosting efficiency, resilience, and customer experience in a volatile market.

With new executive leadership, AI firm HealthLeap aims to accelerate its mission of improving patient outcomes and hospital finances nationwide.

A new video shows Vitestro's Aletta® robot drawing blood. Can this AI-powered device solve staffing shortages and improve patient care worldwide?

AI firm Owkin is leveraging NVIDIA's powerful computing to build a 'Biological Artificial Super Intelligence,' aiming to revolutionize drug discovery.

LyfeSci's acquisition of Clinically Media aims to fix the clinical trial bottleneck by integrating patient recruitment, promising faster, more diverse studies.

Formerly CallTrackingMetrics, CTM unveils a new identity and AI platform, targeting enterprise clients with advanced, unified conversation intelligence.